Medexus Pharmaceuticals Inc. (OTCMKTS:MEDXF – Get Free Report) saw a large growth in short interest in May. As of May 15th, there was short interest totalling 151,400 shares, a growth of 26.9% from the April 30th total of 119,300 shares. Based on an average trading volume of 13,300 shares, the days-to-cover ratio is presently 11.4 […]
Shares of Medexus Pharmaceuticals Inc. (OTCMKTS:MEDXF – Get Free Report) traded up 1.7% on Tuesday . The stock traded as high as $1.20 and last traded at $1.19. 10,036 shares were traded during trading, a decline of 44% from the average session volume of 17,766 shares. The stock had previously closed at $1.17. Medexus Pharmaceuticals […]
Medexus Pharmaceuticals Inc.: Medexus Concludes Metoject Litigation, Patent No Longer in Effect in Canada finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
On March 26, 2024, the Federal Court dismissed Medexus and Medac’s action for patent infringement of Canadian Patent No 2,659,662 (the 662 Patent), finding the asserted claims invalid.
Medexus Pharmaceuticals Inc.: Medexus to Participate in the 2024 Bloom Burton & Co. Healthcare Investor Conference finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.